Ovid Therapeutics Inc (NASDAQ:OVID)
| 2.58 Delayed Data As of Mar 30 |  -0.12 / -4.44%Today’s Change | 1.41 Today|||52-Week Range 3.36 | +38.71% Year-to-Date |
Latest OVID News | Press Releases
No recent news for Ovid Therapeutics Inc.
Today’s Trading
| Previous close | 2.70 |
| Today’s open | 2.64 |
| Day’s range | 2.41 - 2.64 |
| Volume | 3,120 |
| Average volume (3 months) | 82,690 |
| Market cap | $184.7M |
Data as of 3:59pm ET, 03/30/2023
Growth & Valuation
| Earnings growth (last year) | -143.31% |
| Earnings growth (this year) | +7.02% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -99.28% |
| P/E ratio | NM |
| Price/Sales | 87.17 |
| Price/Book | 1.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FULCFulcrum Therapeutics... | -0.32 | -10.19% |
| PDSBPDS Biotechnology Co... | -0.16 | -2.66% |
| ---- | ||
| GNFTGenfit SA | +0.13 | +3.38% |
Data as of 3:59pm ET, 03/30/2023
Financials
| Next reporting date | May 9, 2023 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $1.5M |
| Annual profit (last year) | -$54.2M |
| Net profit margin | -3,604.66% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
